表紙
市場調查報告書

RNA定序的全球市場 - 分析與預測:2019-2028年

Global RNA Sequencing Market: Focus on Product, Technology, Workflow, End User, Application, Region, and Competitive Landscape - Analysis and Forecast, 2019-2028

出版商 BIS Research Inc. 商品編碼 929402
出版日期 內容資訊 英文 276 Pages
商品交期: 最快1-2個工作天內
價格
RNA定序的全球市場 - 分析與預測:2019-2028年 Global RNA Sequencing Market: Focus on Product, Technology, Workflow, End User, Application, Region, and Competitive Landscape - Analysis and Forecast, 2019-2028
出版日期: 2020年03月11日內容資訊: 英文 276 Pages
簡介

全球DNA定序市場規模在2019年∼2028年的預測期間內,預計將以14.21%的年複合成長率大幅度成長。2019年的該市場收益為10億6,460萬美金。這個市場規模至2028年預計將達到35億2,100萬美元的規模。

RNA定序市場成長,由於個人化醫療的採用增加,患者分層化和治療反應研究的效用增加,為了研究開發的實施籌措大量外部資金等而受到促進。

本報告涵括全球RNA定序市場,提供市場動態,競爭環境,各市場區隔、各地區的市場,競爭情形,及主要企業等相關之詳細分析。

摘要整理

第1章 產品定義

第2章 市場範圍

第3章 調查手法

  • 全球RNA定序市場:調查手法
  • 資料來源
  • 2次資料來源
  • 市場預測模式
  • 公司分析的標準

第4章 RNA定序:概要

  • RNA定序現況
  • 市場足跡與未來的可能性
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 其他地區
  • 技術評估
  • 商業化平台應用

第5章 產業分析

  • 相關法規
    • 美國
    • 歐洲
    • 日本
  • 專利形勢
  • RNA定序成本比較
  • 出版統計

第6章 全球RNA定序市場:市場動態

  • 概要
  • 市場動態的影響分析
  • 市場成長要素
    • 由於定序成本的減少使個人化醫療的採用增加
    • 效果預測生物標記及治療反應研究中效用的高漲
    • 為了實施研究開發的高額外部資金
  • 市場阻礙因素
    • 美國的醫療保險制度改革法 (PPACA)的實施
    • 訴訟的存在
    • 高額的資本要求妨礙全球性擴大
  • 市場機會
    • 可攜式且成本效率高的技術的開發
    • 技術的雜合反應

第7章 競爭情形

  • 主要策略、開發
  • 市場佔有率分析
  • 成長佔有率分析:各企業

第8章 全球RNA定序市場:各產品類型

  • 概要
  • 設備
    • 完全自動系統
    • 半自動設備
  • 試劑、套件
    • 樣品濃縮
    • 樣品的分離、提取
    • 程序庫製作
    • 定序
  • 軟體

第9章 全球RNA定序市場:各技術

  • 概要
  • 單一分子型序列
  • 定序:合成各技術
  • 奈米孔洞定序技術
  • Ion Torrent的半導體定序

第10章 全球RNA定序市場:各工作流程

  • 概況
  • 樣品的分離與提取
  • 樣品濃縮
  • 程序庫製作
  • 定序
  • 資料分析、管理

第11章 全球RNA定序市場:各終端用戶

  • 概要
  • 生物醫藥品
  • 診斷中心
  • 生命科學及生物科技企業
  • 研究、學術機構

第12章 全球RNA定序市場:各用途

  • 概要
  • 診斷
  • 藥物研發
  • 轉化醫學
  • 其他

第13章 全球RNA定序市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他地區

第14章 企業簡介

  • 概要
  • Agilent Technologies,Inc.
  • Bio-Rad Laboratories, Inc.
  • BGI
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • Illumina, Inc.
  • Lexogen GmbH
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Dolomite Bio
  • Merck KGaA
  • Becton, Dickinson and Company
  • TaKaRa BIO
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
目錄
Product Code: BH189A

Global RNA Sequencing Market to Reach $3,521.0 Million by 2028

Key Questions Answered in this Report:

  • What are the major market drivers, restraining factors, and opportunities in the global RNA sequencing market?
  • What are the underlying structures resulting in the emerging trends within the global RNA sequencing market?
  • What are the key development strategies which are incorporated by the major players in order to sustain in the competitive market?
  • What are the key regulatory implications in developed and developing regions for RNA sequencing?
  • What are the key patents obtained by the companies for various technologies in the global RNA sequencing market?
  • How each segment of the market is anticipated to grow during the forecast period 2019 to 2028 and what is the estimated revenue to be generated by each of the segments on the basis of:
    • product type, including types of instruments, reagents and kits, and software
    • technology, including, single-molecule-based sequencing, sequence by synthesis technology, nanopore sequencing technology, and ion torrent sequencing technology
    • workflow, including sample enrichment, nucleic acid isolation and extraction, library preparation, sequencing, and data analysis and management
    • end user, including biopharmaceuticals, life science and biotechnology companies, diagnostic centers, and research and academia
    • applications, including drug discovery, translational medicine, diagnostics, and others
    • region, including North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World
  • Who are the leading players with significant offering to the global RNA sequencing market? What is the anticipated market dominance for each of these leading players?
  • Which companies are anticipated to be highly disruptive in the future and why?
  • What are the challenges in the global RNA sequencing market currently?

Global RNA sequencing Market Forecast, 2019-2028

The RNA sequencing industry analysis by BIS Research projects the market to grow at a significant CAGR of 14.21% during the forecast period, 2019-2028. The RNA sequencing market generated $1,064.6 million revenue in 2019, in terms of value. The RNA sequencing market growth has been primarily attributed to the major drivers in this market, such as an increase in adoption of personized medicine, increased utility in patient stratification and therapeutic response research, and significant external funding for executing research and development. However, the expected implementation of patient protection and affordable care act in the U.S., existing lawsuits, and lack of approval with uncertain reimbursement and regulatory policies, among others.

Expert Quote

"We are proud to continue our tradition of driving down the cost of sequencing without compromising accuracy. Products are designed to enable core labs, small to medium research labs, and clinical facilities to access high-intensity sequencing applications using our industry-leading SBS technology."

Scope of the Market Intelligence on RNA sequencing Market

The RNA sequencing research provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers. In addition, the study also includes exhaustive information on the challenges, opportunities, perception of the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global RNA sequencing market.

Market Segmentation

  • The RNA sequencing market (on the basis of manufacturer) is segmented into product, technology, workflow, end user, application, and region.
  • The RNA sequencing market (on the basis of product) is segmented into instruments, reagents and kits, and software.
  • The RNA sequencing market (on the basis of technology) is segmented into single molecule-based sequencing, sequence by synthesis technology, nanopore sequencing technology, and ion torrent semiconductor sequencing.
  • The RNA sequencing market (on the basis of workflow) is segmented into sample enrichment, nucleic acid isolation and extraction, library preparation, sequencing, and data analysis and management.
  • The RNA sequencing market (on the basis of end user) is segmented into biopharmaceuticals, life-sciences and biotechnology companies, diagnostic centers, and research and academia.
  • The RNA sequencing market (on the basis of application) is segmented into drug discovery, translational medicine, diagnostics, and others.

Key Companies in the RNA Sequencing Market

The key manufacturers who have been contributing significantly to the RNA sequencing market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BGI, F. Hoffmann La-Roche AG, Fluidigm Corporation, Illumina, Inc., Lexogen GmbH, Oxford Nanopore Technologies, Pacific Biosciences, QIAGEN N.V., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Dolomite Bio, Takara Bio Inc., and Merck KGaA., among others.

Table of Contents

Executive Summary

1 Product Definition

  • 1.1 Inclusion and Exclusion

2 Market Scope

  • 2.1 Scope of Work
  • 2.2 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Global RNA Sequencing Market: Research Methodology
  • 3.2 Data Sources
  • 3.3 Secondary Data Sources
  • 3.4 Market Estimation Model
  • 3.5 Criteria for Company Profiling

4 RNA Sequencing: Overview

  • 4.1 Current State of RNA Sequencing
  • 4.2 Market Footprint and Future Potential
    • 4.2.1 North America
      • 4.2.1.1 Future Potential
    • 4.2.2 Europe
      • 4.2.2.1 Future Potential
    • 4.2.3 Asia-Pacific
      • 4.2.3.1 Future Potential
    • 4.2.4 Latin America
      • 4.2.4.1 Future Potential
    • 4.2.5 Rest-of-the-World
      • 4.2.5.1 Future Potential
  • 4.3 Technology Assessment
  • 4.4 Commercialized Platforms and Applications

5 Industry Analysis

  • 5.1 Legal and Regulatory Framework
    • 5.1.1 U.S.
      • 5.1.1.1 Guidelines Published in FY2018
      • 5.1.1.2 Guidelines Published in FY2016
    • 5.1.2 Europe
    • 5.1.3 Japan
  • 5.2 Patent Landscape
  • 5.3 Comparison of RNA Sequencing Costs
  • 5.4 Publication Statistics

6 Global RNA Sequencing Market: Market Dynamics

  • 6.1 Overview
  • 6.2 Impact Analysis of Market Dynamics
  • 6.3 Market Drivers
    • 6.3.1 Increase in Adoption of Personalized Medicine due to Decrease in Cost of Sequencing
    • 6.3.2 Increased Utility in Predictive Biomarkers and Therapeutic Response Research
    • 6.3.3 Significant External Funding for Executing Research and Development
  • 6.4 Market Restraints
    • 6.4.1 Expected Implementation of Patient Protection and Affordable Care Act in the U.S
    • 6.4.2 Existing Lawsuits
    • 6.4.3 High Capital Requirement Hampering the Expansion of Global Reach
  • 6.5 Market Opportunities
    • 6.5.1 Development of Portable and Cost-Efficient Technologies
    • 6.5.2 Hybridization of Technologies

7 Competitive Landscape

  • 7.1 Key Strategies and Developments
    • 7.1.1 Product Launch and Upgradations
    • 7.1.2 Synergistic Activities
    • 7.1.3 Funding and Expansions
    • 7.1.4 Mergers and Acquisitions
    • 7.1.5 Product Approvals
  • 7.2 Market Share Analysis
  • 7.3 Growth Share Analysis (by Companies), 2018

8 Global RNA Sequencing Market (by Product Type)

  • 8.1 Overview
  • 8.2 Instruments
    • 8.2.1 Fully Automated Systems
    • 8.2.2 Semi-Automated Instruments
  • 8.3 Reagents and Kits
    • 8.3.1 Sample Enrichment
    • 8.3.2 Sample Isolation and Extraction
    • 8.3.3 Library Preparation
    • 8.3.4 Sequencing
  • 8.4 Software

9 Global RNA Sequencing Market (by Technology), 2018-2028

  • 9.1 Overview
  • 9.2 Single Molecule Based Sequencing
  • 9.3 Sequence by Synthesis Technology
  • 9.4 Nanopore Sequencing Technology
  • 9.5 Ion Torrent Semiconductor Sequencing

10 Global RNA Sequencing Market (by Workflow), 2018-2028

  • 10.1 Overview
  • 10.2 Sample Isolation and Extraction
    • 10.2.1 Market Size and Future Potential
  • 10.3 Sample Enrichment
    • 10.3.1 Market Size and Future Potential
  • 10.4 Library Preparation
    • 10.4.1 Market Size and Future Potential
  • 10.5 Sequencing
    • 10.5.1 Market Size and Future Potential
  • 10.6 Data Analysis and Management
    • 10.6.1 Market Size and Future Potential

11 Global RNA Sequencing Market (by End User), 2018-2028

  • 11.1 Overview
  • 11.2 Biopharmaceuticals
  • 11.3 Diagnostic Centers
  • 11.4 Life-sciences and Biotechnology Companies
  • 11.5 Research and Academia

12 Global RNA Sequencing Market (by Application), 2018-2028

  • 12.1 Overview
  • 12.2 Diagnostics
    • 12.2.1 Market Size and Future Potential
  • 12.3 Drug Discovery
    • 12.3.1 Market Size and Future Potential
  • 12.4 Translational Medicine
    • 12.4.1 Market Size and Future Potential
  • 12.5 Others

13 Global RNA Sequencing Market, by Region

  • 13.1 Overview
  • 13.2 North America
    • 13.2.1 Key Dynamics
    • 13.2.2 Competitive Landscape
    • 13.2.3 U.S.
      • 13.2.3.1 Market Size and Growth Potential
      • 13.2.3.2 New Market Opportunities
      • 13.2.3.3 Unmet Needs
    • 13.2.4 Canada
      • 13.2.4.1 Market Size and Growth Potential
      • 13.2.4.2 New Market Opportunities
      • 13.2.4.3 Unmet Needs
  • 13.3 Europe
    • 13.3.1 Key Dynamics
    • 13.3.2 Competitive Landscape
    • 13.3.3 Germany
      • 13.3.3.1 Market Size and Growth Potential
      • 13.3.3.2 New Market Opportunities
      • 13.3.3.3 Unmet Needs
    • 13.3.4 U.K.
      • 13.3.4.1 Market Size and Growth Potential
      • 13.3.4.2 New Market Opportunities
      • 13.3.4.3 Unmet Needs
    • 13.3.5 France
      • 13.3.5.1 Market Size and Growth Potential
      • 13.3.5.2 New Market Opportunities
      • 13.3.5.3 Unmet Needs
    • 13.3.6 Italy
      • 13.3.6.1 Market Size and Growth Potential
      • 13.3.6.2 New Market Opportunities
      • 13.3.6.3 Unmet Needs
    • 13.3.7 Spain
      • 13.3.7.1 Market Size and Growth Potential
      • 13.3.7.2 New Market Opportunities
      • 13.3.7.3 Unmet Needs
    • 13.3.8 Russia
      • 13.3.8.1 Market Size and Growth Potential
    • 13.3.9 Rest-of-Europe
  • 13.4 Asia-Pacific
    • 13.4.1 Key Dynamics
    • 13.4.2 Competitive Landscape
    • 13.4.3 China
      • 13.4.3.1 Market Size and Growth Potential
      • 13.4.3.2 New Market Opportunities
      • 13.4.3.3 Unmet Needs
    • 13.4.4 Japan
      • 13.4.4.1 Market Size and Growth Potential
      • 13.4.4.2 New Market Opportunities
      • 13.4.4.3 Unmet Needs
    • 13.4.5 India
      • 13.4.5.1 Market Size and Growth Potential
      • 13.4.5.2 New Market Opportunities
      • 13.4.5.3 Unmet Needs
    • 13.4.6 Australia
      • 13.4.6.1 Market Size and Growth Potential
      • 13.4.6.2 New Market Opportunities
      • 13.4.6.3 Unmet Needs
    • 13.4.7 South Korea
      • 13.4.7.1 Market Size and Growth Potential
      • 13.4.7.2 New Market Opportunities
      • 13.4.7.3 Unmet Needs
    • 13.4.8 Rest-of-APAC
  • 13.5 Latin America
    • 13.5.1 Key Dynamics
    • 13.5.2 Brazil
      • 13.5.2.1 Market Size and Growth Potential
      • 13.5.2.2 New Market Opportunities
      • 13.5.2.3 Unmet Needs
    • 13.5.3 Mexico
      • 13.5.3.1 Market Size and Growth Potential
      • 13.5.3.2 New Market Opportunities
      • 13.5.3.3 Unmet Needs
    • 13.5.4 Rest-of-Latin America
  • 13.6 Rest-of-the-World
    • 13.6.1 Key Dynamics
      • 13.6.1.1 New Market Opportunities
      • 13.6.1.2 Unmet Needs

14 Company Profiles

  • 14.1 Overview
  • 14.2 Agilent Technologies, Inc.
    • 14.2.1 Company Overview
    • 14.2.2 Role of Agilent Technologies, Inc. in the Global RNA Sequencing Market
    • 14.2.3 Financials
    • 14.2.4 Key Insights About Financial Health of the Company
    • 14.2.5 SWOT Analysis
  • 14.3 Bio-Rad Laboratories, Inc.
    • 14.3.1 Company Overview
    • 14.3.2 Role of Bio-Rad Laboratories, Inc. in the Global RNA Sequencing Market
    • 14.3.3 Financials
    • 14.3.4 Key Insights About Financial Health of the Company
    • 14.3.5 SWOT Analysis
  • 14.4 BGI
    • 14.4.1 Company Overview
    • 14.4.2 Role of BGI in the Global RNA Sequencing Market
    • 14.4.3 Financials
    • 14.4.4 Key Insights About Financial Health of the Company
    • 14.4.5 SWOT Analysis
  • 14.5 F. Hoffmann-La Roche AG
    • 14.5.1 Company Overview
    • 14.5.2 Role of F. Hoffmann-La Roche AG in the Global RNA Sequencing Market
    • 14.5.3 Financials
    • 14.5.4 Key Insights About Financial Health of the Company
    • 14.5.5 SWOT Analysis
  • 14.6 Fluidigm Corporation
    • 14.6.1 Company Overview
    • 14.6.2 Role of Fluidigm Corporation in the Global RNA Sequencing Market
    • 14.6.3 Financials
    • 14.6.4 Key Insights About Financial Health of the Company
    • 14.6.5 SWOT Analysis
  • 14.7 Illumina, Inc.
    • 14.7.1 Company Overview
    • 14.7.2 Role of Illumina, Inc. in the Global RNA Sequencing Market
    • 14.7.3 Financials
    • 14.7.4 Key Insights About Financial Health of the Company
    • 14.7.5 SWOT Analysis
  • 14.8 Lexogen GmbH
    • 14.8.1 Company Overview
    • 14.8.2 Role of Lexogen GmbH in the Global RNA Sequencing Market
    • 14.8.3 SWOT Analysis
  • 14.9 Oxford Nanopore Technologies
    • 14.9.1 Company Overview
    • 14.9.2 Role of Oxford Nanopore Technologies in the Global RNA Sequencing Market
    • 14.9.3 SWOT Analysis
  • 14.10 Pacific Biosciences
    • 14.10.1 Company Overview
    • 14.10.2 Role of Pacific Biosciences in the Global RNA Sequencing Market
    • 14.10.3 Financials
    • 14.10.4 Key Insights About Financial Health of the Company
    • 14.10.5 SWOT Analysis
  • 14.11 Dolomite Bio
    • 14.11.1 Company Overview
    • 14.11.2 Role of Dolomite Bio. In the Global RNA Sequencing Market
    • 14.11.3 SWOT Analysis
  • 14.12 Merck KGaA
    • 14.12.1 Company Overview
    • 14.12.2 Role of Merck KGaA in the Global RNA Sequencing Market
    • 14.12.3 Financials
    • 14.12.4 Key Insights About Financial Health of the Company
    • 14.12.5 SWOT Analysis
  • 14.13 Becton, Dickinson and Company
    • 14.13.1 Company Overview
    • 14.13.2 Role of Becton, Dickinson and Company in the Global RNA Sequencing Market
    • 14.13.3 Financials
    • 14.13.4 Key Insights About Financial Health of the Company
    • 14.13.5 SWOT Analysis
  • 14.14 Takara Bio Inc.
    • 14.14.1 Company Overview
    • 14.14.2 Role of Takara Bio Inc. in the Global RNA Sequencing Market
    • 14.14.3 Financials
    • 14.14.4 Key Insights About Financial Health of the Company
    • 14.14.5 SWOT Analysis
  • 14.15 QIAGEN N.V.
    • 14.15.1 Company Overview
    • 14.15.2 Role of QIAGEN N.V. plc in the Global RNA Sequencing Market
    • 14.15.3 Financials
    • 14.15.4 Key Insights About Financial Health of the Company
    • 14.15.5 SWOT Analysis
  • 14.16 Thermo Fisher Scientific Inc.
    • 14.16.1 Company Overview
    • 14.16.2 Role of Thermo Fisher Scientific in the Global RNA Sequencing Market
    • 14.16.3 Financials
    • 14.16.4 Key Insights About Financial Health of the Company
    • 14.16.5 SWOT Analysis

List of Tables

  • Table 4.1: Assessment of Existing Technologies in Global RNA Sequencing Market
  • Table 4.2: Key Commercialized Products Offered by Major Market Players
  • Table 5.1: Performance and Cost Comparison of Sequencing Platforms of Various Generations
  • Table 6.1: Cost comparison Analysis of Portable Sequencers
  • Table 8.1: Specifications of Available Instruments in the Market
  • Table 8.2: Respective Offerings of Key Players in Kits Segment
  • Table 8.3: Key Products (Kits and Reagents) Currently Offered by Key Market Players

List of Figures

  • Figure 1: Implications of RNA Sequencing
  • Figure 2: Cumulative Number of Genes Linked to Rare Diseases, 2010-2018
  • Figure 3: Impact Analysis of Market Drivers and Market Challenges on the Global RNA Sequencing Market
  • Figure 4: Global RNA Sequencing Market, by Product Type, 2018 vs. 2028 ($Million)
  • Figure 5: Global RNA Sequencing Market, by Technology, 2018 vs. 2028 ($Million)
  • Figure 6: Global RNA Sequencing Market, by Workflow, 2018 vs. 2028 ($Million)
  • Figure 7: Global RNA Sequencing Market, by End User, 2018 vs. 2028 ($Million)
  • Figure 8: Global RNA Sequencing Market, by Application, 2018 vs. 2028 ($Million)
  • Figure 9: Global RNA Sequencing Market Snapshot
  • Figure 2.1: Global RNA Sequencing Market Segmentation
  • Figure 3.1: Global RNA Sequencing Market Research Methodology
  • Figure 3.2: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.3: Top-Down Approach (Segment-Wise Analysis)
  • Figure 4.1: North America RNA Sequencing Market, 2018-2028
  • Figure 4.2: North America RNA Sequencing Market - Key Driving Factors & Impact
  • Figure 4.3: Europe RNA Sequencing Market, 2018-2028
  • Figure 4.4: Europe RNA Sequencing Market - Key Driving Factors & Impact
  • Figure 4.5: Asia-Pacific RNA Sequencing Market, 2018-2028
  • Figure 4.6: Asia-Pacific RNA Sequencing Market - Key Driving Factors & Impact
  • Figure 4.7: Latin America RNA Sequencing Market, 2018-2028
  • Figure 4.8: Latin America RNA Sequencing Market - Key Driving Factors & Impact
  • Figure 4.9: Rest-of-the-World RNA Sequencing Market, 2018-2028
  • Figure 4.10: Rest-of-the-World RNA Sequencing Market - Key Driving Factors & Impact
  • Figure 5.1: Global RNA Sequencing Market: Existing Patent Segmentation
  • Figure 5.2: NGS RNA Sequencing Publications (2009-2017)
  • Figure 6.1: Impact Analysis of Market Drivers and Restraints
  • Figure 6.2: Cost of Genome Sequencing 2010-2018
  • Figure 6.3: Global RNA Sequencing Market: Funding Scenario (FY2016-FY2019)
  • Figure 7.1: Key Developments and Strategies, 2016-2019
  • Figure 7.2: Product Launch and Upgradations (by Company), 2016-2019
  • Figure 7.3: Synergistic Activities (by Company), 2016 -2019
  • Figure 7.4: Funding and Expansions (by Company), 2016 -2019
  • Figure 7.5: Mergers and Acquisitions Share (by Company), 2016 -2019
  • Figure 7.6: Product Approvals Share (by Company), 2016 -2019
  • Figure 7.7: Market Share Analysis for the Global RNA Sequencing Market, 2018
  • Figure 7.8: Growth Share Matrix for Global RNA Sequencing Market (by Companies), 2018
  • Figure 8.1: Global RNA Sequencing Market (by Product Type)
  • Figure 8.2: Global RNA Sequencing Market (by Product Type), 2019 and 2028
  • Figure 8.3: Global RNA Sequencing Market for Instruments, 2018-2028
  • Figure 8.4: Global RNA Sequencing Market for Fully Automated Instruments, 2018-2028
  • Figure 8.5: Global RNA Sequencing Market for Semi-Automated Instruments, 2018-2028
  • Figure 8.6: Global RNA Sequencing Market for Reagents and Kits, 2018-2028
  • Figure 8.7: Global Sample Enrichment Reagent and Kits Market, 2018-2028
  • Figure 8.8: Global Sample Isolation, Extraction Reagent and Kits Market, 2018-2028
  • Figure 8.9: Global Library Preparation Reagent and Kits Market, 2018-2028
  • Figure 8.10: Global Sequencing Reagent and Kits Market, 2018-2028
  • Figure 8.11: Global RNA Sequencing Market for Software, 2018-2028
  • Figure 9.1: Global RNA Sequencing Market (by Technology), 2018-2028
  • Figure 9.2: Global RNA Sequencing Market for Single Molecule Based Sequencing Technology Segment, 2018-2028
  • Figure 9.3: Global RNA Sequencing Market for Sequence by Synthesis Technology Segment, 2018-2028
  • Figure 9.4: Global RNA Sequencing Market for Nanopore Sequencing Technology Segment, 2018-2028
  • Figure 9.5: Global RNA Sequencing Market for Ion Torrent Semiconductor Sequencing Technology Segment, 2018-2028
  • Figure 10.1: Global RNA Sequencing Market (by Workflow), 2019 and 2028
  • Figure 10.2: Global RNA Sequencing Market for Sample Isolation and Extraction, 2018-2028
  • Figure 10.3: Global RNA Sequencing Market for Sample Enrichment, 2018-2028
  • Figure 10.4: Global RNA Sequencing Market for Library Preparation, 2018-2028
  • Figure 10.5: Global RNA Sequencing Market for Sequencing, 2018-2028
  • Figure 10.6: Global RNA Sequencing Market for Data Analysis and Management, 2018-2028
  • Figure 11.1: Global RNA Sequencing Market (by End User)
  • Figure 11.2: Global RNA Sequencing Market (by End User), 2019 and 2028
  • Figure 11.3: Global RNA Sequencing Market for Biopharmaceuticals, 2018-2028
  • Figure 11.4: Global RNA Sequencing Market for Diagnostic Centers, 2018-2028
  • Figure 11.5: Global RNA Sequencing Market for Life-Sciences and Biotechnology Companies, 2018-2028
  • Figure 11.6: Global RNA Sequencing Market for Research and Academia, 2018-2028
  • Figure 12.1: Global RNA Sequencing Market (by Application), 2019 and 2028
  • Figure 12.2: Global RNA Sequencing Market for Diagnostics, 2018-2028
  • Figure 12.3: Global RNA Sequencing Market for Drug Discovery, 2018-2028
  • Figure 12.4: Global RNA Sequencing Market for Translational Medicine, 2018-2028
  • Figure 12.5: Global RNA Sequencing Market for Other Applications Market, 2018-2028
  • Figure 13.1: RNA Sequencing Market (by Region), 2019 and 2028
  • Figure 13.2: RNA Sequencing Market (by Region), 2018-2028
  • Figure 13.3: North America: Market Dynamics
  • Figure 13.4: North America RNA Sequencing Market, (by Country), 2018-2028
  • Figure 13.5: North America: Growth Strategies by Key Market Players, (2016-2019)
  • Figure 13.6: North America: Competitive Assessment of Key Market Players
  • Figure 13.7: U.S. RNA Sequencing Market), 2018-2028
  • Figure 13.8: Canada RNA Sequencing Market, 2018-2028
  • Figure 13.9: Europe: Market Dynamics
  • Figure 13.10: Europe RNA Sequencing Market, (by Country), 2018-2028
  • Figure 13.11: Europe: Growth Strategies by Key Market Players, (2016-2019)
  • Figure 13.12: Europe: Competitive Assessment of Key Market Players
  • Figure 13.13: Germany RNA Sequencing Market, 2018-2028
  • Figure 13.14: U.K. RNA Sequencing Market, 2018-2028
  • Figure 13.15: France RNA Sequencing Market, 2018-2028
  • Figure 13.16: Italy RNA Sequencing Market, 2018-2028
  • Figure 13.17: Spain RNA Sequencing Market, 2018-2028
  • Figure 13.18: Russia RNA Sequencing Market, 2018-2028
  • Figure 13.19: Rest-of-Europe RNA Sequencing Market, 2018-2028
  • Figure 13.20: Asia-Pacific: Market Dynamics
  • Figure 13.21: Asia-Pacific RNA Sequencing Market, (by Country), 2018-2028
  • Figure 13.22: Asia-Pacific: Growth Strategies by Key Market Players, (2016-2019)
  • Figure 13.23: Asia-Pacific: Competitive Assessment of Key Market Players
  • Figure 13.24: China RNA Sequencing Market, 2018-2028
  • Figure 13.25: Japan RNA Sequencing Market, 2018-2028
  • Figure 13.26: India RNA Sequencing Market, 2018-2028
  • Figure 13.27: Australia RNA Sequencing Market, 2018-2028
  • Figure 13.28: South Korea RNA Sequencing Market, 2018-2028
  • Figure 13.29: Rest-of-APAC RNA Sequencing Market, 2018-2028
  • Figure 13.30: Latin America: Market Dynamics
  • Figure 13.31: Latin America RNA Sequencing Market, (by Country), 2018-2028
  • Figure 13.32: Brazil RNA Sequencing Market, 2018-2028
  • Figure 13.33: Mexico RNA Sequencing Market, 2018-2028
  • Figure 13.34: Rest-of-Latin America RNA Sequencing Market, 2018-2028
  • Figure 13.35: Rest-of-the-World: Market Dynamics
  • Figure 13.36: Rest-of-the-World RNA Sequencing Market, 2018-2028
  • Figure 14.1: Total Number of Companies Profiled
  • Figure 14.2: Agilent Technologies, Inc.: Overall Product Portfolio
  • Figure 14.3: Agilent Technologies, Inc.: Overall Financials, 2017-2019
  • Figure 14.4: Agilent Technologies, Inc.: Revenue (by Segment), 2017-2019
  • Figure 14.5: Agilent Technologies, Inc.: Revenue (by Region), 2017-2019
  • Figure 14.6: Agilent Technologies, Inc.: R&D Expenditure, 2017-2019
  • Figure 14.7: Agilent Technologies, Inc.: SWOT Analysis
  • Figure 14.8: Bio-Rad Laboratories, Inc.: Overall Product Portfolio
  • Figure 14.9: Bio-Rad Laboratories, Inc.: Overall Financials, 2016-2018
  • Figure 14.10: Bio-Rad Laboratories, Inc.: Sales (by Segment), $Million, 2016-2018
  • Figure 14.11: Bio-Rad Laboratories, Inc.: Sales (by Region), 2016-2018
  • Figure 14.12: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2016-2018
  • Figure 14.13: Bio-Rad Laboratories, Inc.: SWOT Analysis
  • Figure 14.14: BGI: Overall Product Portfolio
  • Figure 14.15: BGI: Overall Financials, 2017-2018
  • Figure 14.16: BGI: Sales (by Segment), 2017-2018
  • Figure 14.17: BGI: Sales (by Region), 2017-2018
  • Figure 14.18: BGI: R&D Expenditure, 2017-2018
  • Figure 14.19: BGI: SWOT Analysis
  • Figure 14.20: F. Hoffmann-La Roche AG: Overall Product Portfolio
  • Figure 14.21: F. Hoffmann-La Roche AG: Overall Financials, 2016-2018
  • Figure 14.22: F. Hoffmann-La Roche AG: Revenue (by Segment), $Million, 2016-2018
  • Figure 14.23: F. Hoffmann-La Roche AG: Revenue (by Region), 2016-2018
  • Figure 14.24: F. Hoffmann-La Roche AG: R&D Expenditure, 2016-2018
  • Figure 14.25: F. Hoffmann-La Roche AG: SWOT Analysis
  • Figure 14.26: Fluidigm Corporation: Overall Product Portfolio
  • Figure 14.27: Fluidigm Corporation: Overall Financials, 2016-2018
  • Figure 14.28: Fluidigm Corporation: Revenue (by Business Segment), 2016-2018
  • Figure 14.29: Fluidigm Corporation: Revenue (by Region), 2016-2018
  • Figure 14.30: Fluidigm Corporation: R&D Expenditure, 2016-2018
  • Figure 14.31: Fluidigm Corporation: SWOT Analysis
  • Figure 14.32: Illumina, Inc.: Overall Product Portfolio
  • Figure 14.33: Illumina, Inc.: Overall Financials, 2016-2018
  • Figure 14.34: Illumina, Inc.: Revenue (by Segment), $Million, 2016-2018
  • Figure 14.35: Illumina, Inc.: Revenue (by Region), 2016-2018
  • Figure 14.36: Illumina, Inc.: R&D Expenditure, 2016-2018
  • Figure 14.37: Illumina, Inc.: SWOT Analysis
  • Figure 14.38: Lexogen GmbH: Overall Product Portfolio
  • Figure 14.39: Lexogen GmbH: SWOT Analysis
  • Figure 14.40: Oxford Nanopore Technologies: Product Offerings
  • Figure 14.41: Oxford Nanopore Technologies: SWOT Analysis
  • Figure 14.42: Pacific Biosciences: Existing Product Offerings in Global RNA Sequencing Market
  • Figure 14.43: Pacific Biosciences: Overall Financials, 2016-2018
  • Figure 14.44: Pacific Biosciences: Revenue (by Region), 2016-2018
  • Figure 14.45: Pacific Biosciences: R&D Expenditure, 2016-2018
  • Figure 14.46: Pacific Biosciences: SWOT Analysis
  • Figure 14.47: Dolomite Bio.: Existing Product Offerings in Global RNA Sequencing Market
  • Figure 14.48: Dolomite Bio.: SWOT Analysis
  • Figure 14.49: Merck KGaA: Existing Product Offerings in the Global RNA Sequencing Market
  • Figure 14.50: Merck KGaA: Overall Financials, 2016-2018
  • Figure 14.51: Merck KGaA: Revenue (by Segment), $Million, 2016-2018
  • Figure 14.52: Merck KGaA: Revenue (by Region), 2016-2018
  • Figure 14.53: Merck KGaA: R&D Expenditure, 2016-2018
  • Figure 14.54: Merck KGaA: SWOT Analysis
  • Figure 14.55: Beckton, Dickinson and Company: Existing Product Offerings in Global RNA Sequencing Market
  • Figure 14.56: Becton, Dickinson and Company: Overall Financials, 2017-2019
  • Figure 14.57: Becton, Dickinson and Company: Revenue (by Business Segment), 2017-2019
  • Figure 14.58: Becton, Dickinson and Company: Revenue Split for BD Life Sciences, 2017-2019
  • Figure 14.59: Becton, Dickinson and Company: Revenue (by Region), 2017-2019
  • Figure 14.60: Becton, Dickinson and Company: R&D Expenditure, 2017-2019
  • Figure 14.61: Becton, Dickinson and Company: SWOT Analysis
  • Figure 14.62: Takara Bio Inc.: Existing Product Offerings in Global RNA Sequencing Market
  • Figure 14.63: Takara Bio Inc.: Overall Financials, 2017-2019
  • Figure 14.64: Takara Bio Inc.: Revenue (by Segment), 2017-2019
  • Figure 14.65: Takara Bio Inc.: Revenue (by Region), 2017-2019
  • Figure 14.66: Takara Bio Inc.: R&D Expenditure, 2017-2019
  • Figure 14.67: Takara Bio Inc.: SWOT Analysis
  • Figure 14.68: QIAGEN N.V.: Existing Product Offerings in Global RNA Sequencing Market
  • Figure 14.69: QIAGEN N.V.: Overall Financials, 2016-2018
  • Figure 14.70: QIAGEN N.V.: Revenue (by Segment), $Million, 2016-2018
  • Figure 14.71: QIAGEN N.V.: Revenue (by Region), 2016-2018
  • Figure 14.72: QIAGEN N.V.: R&D Expenditure, 2016-2018
  • Figure 14.73: QIAGEN N.V.: SWOT Analysis
  • Figure 14.74: Thermo Fisher Scientific Inc.: Existing Product Offerings in Global RNA Sequencing Market
  • Figure 14.75: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
  • Figure 14.76: Thermo Fisher Scientific Inc: Sales (by Segment), $Billion, 2016-2018
  • Figure 14.77: Thermo Fisher Scientific Inc.: Sales (by Region), 2016-2018
  • Figure 14.78: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
  • Figure 14.79: Thermo Fisher Scientific Inc.: SWOT Analysis